Remove Hormones Remove Vaccination Remove Vaccine
article thumbnail

Sanofi snaps up acne vaccine developer Origimm Bio

pharmaphorum

Sanofi has added to its vaccine pipeline with an agreement to acquire Austria’s Origimm Biotechnology and its vaccine-based immunotherapy for people with acne. It will highlight vaccines for pneumococcal disease, meningitis, respiratory syncytial virus (RSV), influenza, and chlamydia. Photo by Scott Webb on Unsplash.

Vaccine 105
article thumbnail

Merck and Orion enter partnership to develop ODM-208 for prostate cancer

Pharmaceutical Technology

Orion discovered and developed ODM-208 to treat hormone-dependent cancers, such as prostate cancer. Merck Research Laboratories president Dr Dean Li said: “Targeting CYP11A1 provides a compelling approach to suppressing the production of steroid hormones, a key driver of prostate cancer. “We

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Why the Potential Effects of COVID-19 Vaccines on the Menstrual Cycle Are Not Concerning

XTalks

There have been growing reports of women experiencing changes in their menstrual cycle after receiving a shot of a COVID-19 vaccine. Some women have said they got their periods early following vaccination, or that their periods were unusually heavy and/or painful. Related: Moderna’s COVID-19 Vaccine Effective Against New Variants.

Vaccine 105
article thumbnail

Type 1 Diabetes Vaccine: Does Diamyd Have a Winning Formula?

XTalks

A vaccine developed by Swedish company Diamyd Medical has demonstrated significant treatment efficacy in a predefined genetic subgroup of individuals with type 1 diabetes in a Phase IIb clinical trial. In the trial, the vaccine was injected directly into the lymph nodes of type 1 diabetic individuals.

Vaccine 103
article thumbnail

Not just COVID-19 vaccines: 5 things that cause blood clots

pharmaphorum

Reports of COVID-19 vaccinations causing blood clots has caused alarm in the general population. However due to the rarity of incidences from vaccination, myGP explores the most common causes of blood clots and how we can prevent them. Because of hormone changes, this can cause blood cells to form clots.

article thumbnail

Pfizer’s Ngenla Approved as Once-Weekly Treatment for Pediatric Growth Hormone Deficiency (GHD)

XTalks

Pfizer has been going strong on the approval front, having secured its fifth US Food and Drug Administration (FDA) approval in the past five weeks, with the most recent being for the company’s once-weekly human growth hormone analog Ngenla (somatrogon-ghla). Pfizer paid OPKO $295 million upfront at the beginning of the partnership.

article thumbnail

Gelteq IPO: Supporting Gel Technology for Oral Drug Delivery

XTalks

Companies like Mallinckrodt, with its SelfJect injector for chronic and autoimmune conditions, and Evofem Biosciences, with its hormone-free Phexxi contraceptive gel , are developing solutions that simplify and improve medication use for patients with specific needs.